Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
A study out of UF and MD Anderson Cancer Center shows patients with advanced lung or skin cancer taking certain drugs lived ...
New Scientist on MSN
Why the next generation of mRNA vaccines is set to be even better
Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...
After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of ...
Just one weekly puff from an asthma-like inhaler might one day protect you from the viral infections that make winters miserable – and could even save your life in the event of another pandemic. That ...
Earlier this month, Waters Corporation launched the Xevo Charge Detection Mass Spectrometer (CDMS), offering direct, individual-particle mass measurement of mega-mass biomolecules critical to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback